Published in
American Society of Hematology, Blood, 7(127), p. 938-947, 2016
DOI: 10.1182/blood-2015-09-671834
Links
- American Society of Hematology | PDF
- ORCID
- [europepmc.org] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
Tools
Reduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donors
Journal article published in 2016 by
Abraham S. Kanate,
Alberto Mussetti 
,
Mohamed A. Kharfan-Dabaja,
Kwang W. Ahn,
Alyssa DiGilio,
Amer Beitinjaneh,
Saurabh Chhabra,
Timothy S. Fenske,
Cesar Freytes,
Robert Peter Gale,
Siddhartha Ganguly,
Mark Hertzberg,
Evgeny Klyuchnikov,
Hillard M. Lazarus,
Richard Olsson
and other authors.
,
Mohamed A. Kharfan-Dabaja,
Kwang W. Ahn,
Alyssa DiGilio,
Amer Beitinjaneh,
Saurabh Chhabra,
Timothy S. Fenske,
Cesar Freytes,
Robert Peter Gale,
Siddhartha Ganguly,
Mark Hertzberg,
Evgeny Klyuchnikov,
Hillard M. Lazarus,
Richard Olsson
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 
Abstract
Key Points Risk of grade III-IV acute and chronic GVHD is significantly lower with haploidentical compared with URD transplantation. Relapse risk, NRM, PFS, and OS was similar in haploidentical transplants compared with unrelated donor transplants.